Clinical Trial Update: A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study Designed to Evaluate the Efficacy of Fexofenadine HCl 180 mg for Preventing and Controlling Cat Allergy Symptoms [Phase 4]

View source ↗

Summary

A phase 4, single-center, randomized, double-blind, placebo-controlled crossover study assessing the efficacy of fexofenadine HCl 180 mg for preventing and cont…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cat-induced Allergic Rhinitis

Drugs mentioned

• Fexofenadine HCl 180 mg (fexofenadine)

Snippet

Sponsor: Sanofi | Conditions: Cat Induced Allergic Rhinitis | Phase 4 | Status: COMPLETED